-- 由於中東關鍵海峽霍爾木茲海峽持續關閉,油價上漲,澳洲股市週四收盤再次下跌。 S&P/ASX 200 指數下跌 0.57%,跌幅 50.20 點,收在 8,793.40 點。 布蘭特原油期貨週四上漲 1.4%,達到每桶 103.3 美元。伊朗扣押了兩艘試圖經由霍爾木茲海峽離開波斯灣的貨櫃船。 華爾街方面,標普 500 指數上漲 1.1%,那斯達克指數上漲 1.6%,創下歷史新高,財報季正式開跑。道瓊指數上漲 0.7%。 國內方面,標普全球(S&P Global)的調查顯示,4月份澳洲綜合採購經理人指數(PMI)初值從3月的46.6升至50.1,突破中性閾值,服務業活動的復甦抵消了製造業產出加速下滑的影響。 繼3月下滑之後,澳洲私部門活動在4月趨於穩定。服務業的溫和復甦被製造業的持續疲軟所抵消,製造業疲軟的原因是國內需求疲軟、成本壓力上升以及與中東緊張局勢相關的供應鏈中斷。 根據Seek發布的數據,澳洲3月的招募廣告數量較上季下降0.4%,較上季下降1.3%,年減2.9%。 公司方面,桑托斯(Santos,ASX:STO)公佈第一季銷售收入約12.7億澳元,低於去年同期的12.9億澳元。本季銷售量為2,420萬桶油當量(mmboe),高於去年同期的2,330萬桶油當量;總產量從去年同期的2,190萬桶油當量增至2,250萬桶油當量。其股價收盤上漲3%。 安普爾(Ampol,ASX:ALD)週三向澳洲競爭與消費者委員會(ACCC)提交了其擬收購EG Australia的最終補救方案,提議將計劃剝離的資產數量從37個增加到41個。其股價收盤上漲超過1%。 最後,米爾瓦克集團(Mirvac Group,ASX:MGR)表示,第三財季住宅銷售額達到592套,較去年同期成長12%。該公司表示,今年迄今的結算數量達到1,076筆,年增15%,2026財年目標批結算已完成約96%,利潤率可望達到18%至22%的目標區間。其股價在收盤時下跌超過1%。
Related Articles
Research Alert: CFRA Keeps Buy Opinion On Shares Of The Hartford Insurance Group, Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We trim our 12-month target price by $8 to $155, valuing HIG shares at 11.3x our 2026 operating EPS estimate of $13.75 (cut by $0.45) and at 10.6x our 2027 EPS estimate of $14.65 (cut by $0.30), vs. the shares' one-year average forward multiple of 10.3x and peer average of 13x. Q1 EPS of $3.09 vs. $2.20 a year ago missed our $3.60 estimate and $3.39 consensus view. Operating revenue growth of 6.2% was in line with our 6%-10% forecast, amid 5.3% earned premium growth, 13% higher net investment income, and 7.9% fee revenue growth. Q1 written premium growth of 4% and full-year 2025 growth of 7% bode well for 2026 revenue trends as premiums are earned. Underwriting results improved significantly, with Personal Lines combined ratio improving to 87.7% from 106.1% and underlying combined ratio to 85.0% from 89.7%. Business Insurance combined ratio was stable at 94.8%. Weighing the Q1 EPS miss with HIG's decent top-line growth and discounted valuation to peers, we view the shares as undervalued.
Research Alert: CFRA Keeps Strong Buy Opinion On Shares Of Baker Hughes
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We raise our 12-month target price by $14 to $82, reflecting a combination of our sum-of-the-parts (SOTP) and DCF models. For our SOTP model, we presume the oilfield services business (about 50% of BKR's franchise) to be valued at about 10x projected 2027 EBITDA (in line with major peers) and its industrial energy technology business (the other 50%) valued at 14x projected 2027 EBITDA (in line with the peer median). This blended approach, yielding a 12x multiple, implies a value of $73 per share. Meanwhile, our DCF model, using medium-term free cash flow growth of 5% per year, terminal growth of 2.5%, discounted at a WACC of 6.3%, yields intrinsic value of $91 per share. We cut our 2026 EPS estimate by $0.47 to $2.48, but we raise 2027's by $0.07 to $3.24. We acknowledge that the oilfield services business is likely to struggle in 2026 owing to the U.S.-Iran conflict, but the IET business appears quite robust and likely to be a source of both accelerating revenue growth and margins.
Research Alert: CFRA Maintains Hold Opinion In Shares Of Wab
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lift our 12-month target to $285 from $275 following WAB's Q1 earnings print, valuing shares at 24.2x our 2027 EPS outlook of $11.76 (revised from $11.46; 2026 EPS estimate up to $10.57 from $10.50), a slight premium to WAB's long-term historical multiple average given structural improvements in earnings quality. While we are cautious on signs of overcapacity in the freight market, an elevated order backlog (12-month sits at over $9 billion), internal initiatives to shore up margins, and potential synergies from M&A activity positions WAB to continue growing earnings at double-digit rates in 2026-2027, in our view. Despite tariff-related cost pressures, WAB has done a commendable job of defending margins via a mix of pricing, lean manufacturing, and pruning of lower-profit operations. Q1 results were mixed but overall positive, in our view. We maintain our Hold recommendation on shares.